TABLE 2.

Change from baseline of mean FACE-Q scores used in chin/lower face filler studies

ARTICLE		Beer, 2021 Derm Surg16		Ogilvie, 2019 Derm Surg17		Mastroluca, 2021 JCD18
PRODUCT		VYC-20L (n = 144)		VYC-25 (n=90)		VYC-25 (n=40)
TREATMENT SITE		Pogonion, Menton, Prejowl sulci		Pogonion, Mentum, Prejowl sulci		Mandibular angle, pre auricular area, mandibular body, pre-jowl sulci, anterior and lateral chin
INJECTION TECHNIQUE		Injection & cannula		Injection only: Serial puncture, tunneling, fanning		Injection & cannula
VOLUME USED (MEAN)		Initial: 1.9mL, Combined Initial + touch up at 1 month: 2.6mL		Initial: 2.28 mL (median), Touch-up: 1.0 mL (median), Combined Initial + touch-up: 3.43 (median)		7.8mL
FOLLOW UP		6 months s/p last treatment	12 months + 1 month s/p retreatment	3 months s/p last treatment	12 months s/p baseline treatment	6 months s/p baseline treatment
CHANGE FROM BASELINE OF MEAN FACE-Q SCORE	SATISFACTION WITH OUTCOME	NR	NR	NR		88.1
	SATISFACTION WITH CHIN	35.6*	42.6	31.4	20.2	NR
	SATISFACTION WITH LOWER FACE/JAWLINE	NR	NR	33.5	23.9	NR
	PSYCHOLOGICAL WELLBEING	15.4	~15.0	13.4	9.1	NR

*Significant (p<0.05) compared to baseline.

NR: not reported; VYC-20L: Juvéderm Voluma® XC with Lidocaine; VYC-25: Juvéderm Volux® with Lidocaine